ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LQDA vs LEGN // ALTMAN Z-SCORE & DEBT/EQUITY

Liquidia Corporation (NASDAQ) VS. Legend Biotech Corporation (NASDAQ) • 15-METRIC TALLY: LQDA 3 — LEGN 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: LQDA
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDA VS. LEGN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LQDA LEGN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -12.60% 9.90% -22.50 LEGN /roic <GO>
EV/EBITDA & P/E Valuation — 21.0x — TIE /valuation <GO>
Free Cash Flow Yield -0.99% 2.21% -3.20 LEGN /fcf-yield <GO>
Operating Margin -32.50% 13.90% -46.40 LEGN /operating-margins <GO>
Net Profit Margin -43.50% 10.90% -54.40 LEGN /net-margins <GO>
Revenue Growth (YoY) 180.00% 9.90% +170.10 LQDA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 6.33 3.74 +2.59 LQDA /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 LEGN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.5 59.2 -6.70 LEGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 1.04 -0.14 LEGN /macro-sensitivity <GO>
Forward P/E Multiple 21.0x 30.5x -9.50 LQDA /forward-pe <GO>
Enterprise Scale & Market Cap $4.03B $4.21B -$173.5M LEGN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LQDA REV LEGN REV LQDA GROSS % LEGN GROSS % LQDA FCF LEGN FCF
FY 2025 $158.3M — — — -$40.0M —
FY 2024 $14.0M — 58.0% — -$98.4M —
FY 2023 $17.5M — — — -$42.4M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDA // BETA 0.90
LEGN // BETA 1.04